Kindeva Drug Delivery

Saint Paul, United States Founded: 2020 • Age: 6 yrs Acquired By Altaris
Injectables and biologics products are manufactured by the CDMO.

About Kindeva Drug Delivery

Kindeva Drug Delivery is a company based in Saint Paul (United States) founded in 2020 was acquired by Altaris in May 2020.. Kindeva Drug Delivery has completed 2 acquisitions, including Summit Biosciences and iPharma Labs. Kindeva Drug Delivery offers products and services including Pressurized Metered-Dose Inhaler, Autoinjector, Breath-Actuated Inhaler, and Drug-in-Adhesive Patch. Kindeva Drug Delivery operates in a competitive market with competitors including Abzena, Patheon, Syngene, Piramal Group and Panacea Biotec, among others.

  • Headquarter Saint Paul, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Kindeva Drug Delivery L.P.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $42.06 M (USD), Grant

    Aug 03, 2023

  • Investors
    Gov.uk

    & 1 more

  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    Altaris

    (May 01, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Kindeva Drug Delivery

Kindeva Drug Delivery offers a comprehensive portfolio of products and services, including Pressurized Metered-Dose Inhaler, Autoinjector, Breath-Actuated Inhaler, and Drug-in-Adhesive Patch. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Device for delivering inhaled medications efficiently.

Self-administered tool for precise drug injection.

Inhaler activated by breathing for easier use.

Patch for extended, noninvasive drug administration.

People of Kindeva Drug Delivery
Headcount 500-1000
Employee Profiles 179
Employee Profiles
People
Abigail Barlow
Compliance Coordinator
People
Randy Johnson
Manager/tl Logistics-warehouse Operations
People
Gareth C.
Advanced Value Stream Compliance Engineer
People
Tammy Powell
Senior Category Manager, Container Closure Systems, US

Unlock access to complete

Funding Insights of Kindeva Drug Delivery

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $42.1M
  • First Round

    (03 Aug 2023)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2023 Amount Grant - Kindeva Drug Delivery Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Kindeva Drug Delivery

Kindeva Drug Delivery has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk and Altaris. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
PE firm invests in the US
Founded Year Domain Location
Online government services and information are provided to users.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Kindeva Drug Delivery

Kindeva Drug Delivery has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Summit Biosciences and iPharma Labs. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Inhalation product testing, development, and consulting services are provided.
2016
Nasal spray drug products are developed, manufactured, and commercialized.
2008
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Kindeva Drug Delivery

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Kindeva Drug Delivery Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Kindeva Drug Delivery

Kindeva Drug Delivery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abzena, Patheon, Syngene, Piramal Group and Panacea Biotec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of antibody discovery, cell line development, and bio analytics services
domain founded_year HQ Location
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
domain founded_year HQ Location
Provider of contract research and manufacturing services for both small molecules and biologics
domain founded_year HQ Location
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
domain founded_year HQ Location
Developer of biosimilars, vaccines and natural products
domain founded_year HQ Location
Provides enabling tools and services in the life sciences research and bio-production industries
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Kindeva Drug Delivery

Frequently Asked Questions about Kindeva Drug Delivery

When was Kindeva Drug Delivery founded?

Kindeva Drug Delivery was founded in 2020 and raised its 1st funding round 3 years after it was founded.

Where is Kindeva Drug Delivery located?

Kindeva Drug Delivery is headquartered in Saint Paul, United States. It is registered at Saint Paul, Minnesota, United States.

Who is the current CEO of Kindeva Drug Delivery?

Aaron Mann is the current CEO of Kindeva Drug Delivery.

What does Kindeva Drug Delivery do?

Kindeva Drug Delivery was founded in 2020 and is headquartered in Saint Paul, United States. Contract development and manufacturing organization services are provided in the pharmaceutical sector, with a focus on injectable and biologic products. Operations involve production for various clients, supporting drug delivery solutions across the industry from the U.S. base.

Who are the top competitors of Kindeva Drug Delivery?

Kindeva Drug Delivery's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.

What products or services does Kindeva Drug Delivery offer?

Kindeva Drug Delivery offers Pressurized Metered-Dose Inhaler, Autoinjector, Breath-Actuated Inhaler, and Drug-in-Adhesive Patch.

How many acquisitions has Kindeva Drug Delivery made?

Kindeva Drug Delivery has made 2 acquisitions, including Summit Biosciences, and iPharma Labs.

Who are Kindeva Drug Delivery's investors?

Kindeva Drug Delivery has 2 investors. Key investors include Gov.uk, and Altaris.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available